Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$25.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 27 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 86 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Sep 15 | GILD | Gilead Sciences, INC. | SSELL◷ | 1,600 | $143.69 | $229.9K | -1.3% | Open the original filing on SEC.gov |
| Sep 10 | GILD | Gilead Sciences, INC. | MEXER◆ | 2,797 | — | — | — | Open the original filing on SEC.gov |
| Sep 10 | GILD | Gilead Sciences, INC. | FTAX | 1,347 | $144.81 | $195.1K | -1.1% | Open the original filing on SEC.gov |
| Sep 10 | GILD | Gilead Sciences, INC. | MEXER | 2,797 | — | — | +2.4% | Open the original filing on SEC.gov |
| Aug 17 | GILD | Gilead Sciences, INC. | MEXER◷◆ | 1,890 | — | — | — | Open the original filing on SEC.gov |
| Aug 17 | GILD | Gilead Sciences, INC. | MEXER◷◆ | 23,110 | — | — | — | Open the original filing on SEC.gov |
| Aug 17 | GILD | Gilead Sciences, INC. | SSELL◷ | 11,470 | $138.04 | $1.6M | -8.8% | Open the original filing on SEC.gov |
| Aug 17 | GILD | Gilead Sciences, INC. | SSELL◷ | 16,530 | $137.37 | $2.3M | -11.3% | Open the original filing on SEC.gov |
| Aug 17 | GILD | Gilead Sciences, INC. | MEXER◷ | 1,890 | $72.34 | $136.7K | +1.3% | Open the original filing on SEC.gov |
| Aug 17 | GILD | Gilead Sciences, INC. | MEXER◷ | 23,110 | $66.64 | $1.5M | +19.1% | Open the original filing on SEC.gov |
| Jul 15 | GILD | Gilead Sciences, INC. | SSELL◷ | 3,000 | $129.92 | $389.8K | -2.4% | Open the original filing on SEC.gov |
| Jun 15 | GILD | Gilead Sciences, INC. | SSELL◷ | 450 | $125.40 | $56.4K | -0.4% | Open the original filing on SEC.gov |
| Jun 15 | GILD | Gilead Sciences, INC. | SSELL◷ | 1,070 | $124.00 | $132.7K | -0.9% | Open the original filing on SEC.gov |
| Jun 15 | GILD | Gilead Sciences, INC. | SSELL◷ | 1,480 | $123.42 | $182.7K | -1.2% | Open the original filing on SEC.gov |
| Jun 10 | GILD | Gilead Sciences, INC. | MEXER◆ | 2,796 | — | — | — | Open the original filing on SEC.gov |
| Jun 10 | GILD | Gilead Sciences, INC. | FTAX | 1,341 | $121.48 | $162.9K | -1.0% | Open the original filing on SEC.gov |
| Jun 10 | GILD | Gilead Sciences, INC. | MEXER | 2,796 | — | — | +2.2% | Open the original filing on SEC.gov |
| May 27 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 2,567 | — | — | — | Open the original filing on SEC.gov |
| May 21 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 3,318 | — | — | — | Open the original filing on SEC.gov |
| May 21 | NBIX | Neurocrine Biosciences INC | MEXER | 3,318 | — | — | +93.9% | Open the original filing on SEC.gov |
| May 15 | GILD | Gilead Sciences, INC. | MEXER◷◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| May 15 | GILD | Gilead Sciences, INC. | SSELL◷ | 700 | $132.75 | $92.9K | -0.5% | Open the original filing on SEC.gov |
| May 15 | GILD | Gilead Sciences, INC. | SSELL◷ | 8,374 | $132.23 | $1.1M | -6.2% | Open the original filing on SEC.gov |
| May 15 | GILD | Gilead Sciences, INC. | SSELL◷ | 11,177 | $131.19 | $1.5M | -7.6% | Open the original filing on SEC.gov |
| May 15 | GILD | Gilead Sciences, INC. | SSELL◷ | 7,749 | $130.29 | $1M | -5.0% | Open the original filing on SEC.gov |
| May 15 | GILD | Gilead Sciences, INC. | MEXER◷ | 25,000 | $66.64 | $1.7M | +19.4% | Open the original filing on SEC.gov |
| Apr 15 | GILD | Gilead Sciences, INC. | SSELL◷ | 3,000 | $140.96 | $422.9K | -2.3% | Open the original filing on SEC.gov |
| Mar 16 | GILD | Gilead Sciences, INC. | SSELL◷ | 3,000 | $144.23 | $432.7K | -2.2% | Open the original filing on SEC.gov |
| Mar 10 | GILD | Gilead Sciences, INC. | AGRANT◆ | 35,880 | — | — | — | Open the original filing on SEC.gov |
| Mar 10 | GILD | Gilead Sciences, INC. | AGRANT◆ | 9,590 | — | — | — | Open the original filing on SEC.gov |
| Mar 10 | GILD | Gilead Sciences, INC. | MEXER◆ | 6,617 | — | — | — | Open the original filing on SEC.gov |
| Mar 10 | GILD | Gilead Sciences, INC. | FTAX | 3,216 | $148.56 | $477.8K | -2.3% | Open the original filing on SEC.gov |
| Mar 10 | GILD | Gilead Sciences, INC. | MEXER | 6,617 | — | — | +5.0% | Open the original filing on SEC.gov |
| Feb 27 | GILD | Gilead Sciences, INC. | AGRANT | 11,090 | — | — | +9.2% | Open the original filing on SEC.gov |
| Feb 17 | GILD | Gilead Sciences, INC. | MEXER◷◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 17 | GILD | Gilead Sciences, INC. | SSELL◷ | 200 | $155.62 | $31.1K | -0.2% | Open the original filing on SEC.gov |
| Feb 17 | GILD | Gilead Sciences, INC. | SSELL◷ | 9,395 | $154.91 | $1.5M | -7.2% | Open the original filing on SEC.gov |
| Feb 17 | GILD | Gilead Sciences, INC. | SSELL◷ | 18,405 | $154.18 | $2.8M | -12.4% | Open the original filing on SEC.gov |
| Feb 17 | GILD | Gilead Sciences, INC. | MEXER◷ | 25,000 | $66.64 | $1.7M | +20.3% | Open the original filing on SEC.gov |
| Feb 3 | GILD | Gilead Sciences, INC. | FTAX | 24,800 | $143.28 | $3.6M | -16.8% | Open the original filing on SEC.gov |
| Feb 3 | GILD | Gilead Sciences, INC. | AGRANT | 44,867 | — | — | +43.5% | Open the original filing on SEC.gov |
| Jan 15 | GILD | Gilead Sciences, INC. | SSELL◷ | 3,000 | $124.31 | $372.9K | -2.8% | Open the original filing on SEC.gov |
| Dec 15, 2025 | GILD | Gilead Sciences, INC. | SSELL◷ | 3,000 | $122.00 | $366K | -2.8% | Open the original filing on SEC.gov |
| Dec 10, 2025 | GILD | Gilead Sciences, INC. | MEXER◆ | 3,842 | — | — | — | Open the original filing on SEC.gov |
| Dec 10, 2025 | GILD | Gilead Sciences, INC. | FTAX | 1,814 | $121.34 | $220.1K | -1.6% | Open the original filing on SEC.gov |
| Dec 10, 2025 | GILD | Gilead Sciences, INC. | MEXER | 3,842 | — | — | +3.6% | Open the original filing on SEC.gov |
| Nov 17, 2025 | GILD | Gilead Sciences, INC. | MEXER◷◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 17, 2025 | GILD | Gilead Sciences, INC. | SSELL◷ | 2,476 | $126.26 | $312.6K | -2.3% | Open the original filing on SEC.gov |
| Nov 17, 2025 | GILD | Gilead Sciences, INC. | SSELL◷ | 25,524 | $125.83 | $3.2M | -18.9% | Open the original filing on SEC.gov |
| Nov 17, 2025 | GILD | Gilead Sciences, INC. | MEXER◷ | 25,000 | $66.64 | $1.7M | +22.7% | Open the original filing on SEC.gov |
| Oct 15, 2025 | GILD | Gilead Sciences, INC. | SSELL◷ | 3,000 | $118.08 | $354.2K | -2.6% | Open the original filing on SEC.gov |
| Sep 15, 2025 | GILD | Gilead Sciences, INC. | SSELL◷ | 3,000 | $113.57 | $340.7K | -2.6% | Open the original filing on SEC.gov |
| Sep 10, 2025 | GILD | Gilead Sciences, INC. | MEXER◆ | 3,844 | — | — | — | Open the original filing on SEC.gov |
| Sep 10, 2025 | GILD | Gilead Sciences, INC. | FTAX | 1,819 | $115.25 | $209.6K | -1.5% | Open the original filing on SEC.gov |
| Sep 10, 2025 | GILD | Gilead Sciences, INC. | MEXER | 3,844 | — | — | +3.4% | Open the original filing on SEC.gov |
| Aug 15, 2025 | GILD | Gilead Sciences, INC. | MEXER◷◆ | 700 | — | — | — | Open the original filing on SEC.gov |
| Aug 15, 2025 | GILD | Gilead Sciences, INC. | MEXER◷◆ | 11,800 | — | — | — | Open the original filing on SEC.gov |
| Aug 15, 2025 | GILD | Gilead Sciences, INC. | MEXER◷◆ | 700 | — | — | — | Open the original filing on SEC.gov |
| Aug 15, 2025 | GILD | Gilead Sciences, INC. | MEXER◷◆ | 11,800 | — | — | — | Open the original filing on SEC.gov |
| Aug 15, 2025 | GILD | Gilead Sciences, INC. | SSELL◷ | 200 | $118.97 | $23.8K | -0.2% | Open the original filing on SEC.gov |
| Aug 15, 2025 | GILD | Gilead Sciences, INC. | SSELL◷ | 2,800 | $118.51 | $331.8K | -2.4% | Open the original filing on SEC.gov |
| Aug 15, 2025 | GILD | Gilead Sciences, INC. | SSELL◷ | 700 | $118.97 | $83.3K | -0.6% | Open the original filing on SEC.gov |
| Aug 15, 2025 | GILD | Gilead Sciences, INC. | MEXER◷ | 700 | $66.64 | $46.6K | +0.6% | Open the original filing on SEC.gov |
| Aug 15, 2025 | GILD | Gilead Sciences, INC. | SSELL◷ | 11,800 | $118.51 | $1.4M | -9.2% | Open the original filing on SEC.gov |
| Aug 15, 2025 | GILD | Gilead Sciences, INC. | MEXER◷ | 11,800 | $66.64 | $786.4K | +10.1% | Open the original filing on SEC.gov |
| Aug 15, 2025 | GILD | Gilead Sciences, INC. | SSELL◷ | 700 | $118.97 | $83.3K | -0.6% | Open the original filing on SEC.gov |
| Aug 15, 2025 | GILD | Gilead Sciences, INC. | MEXER◷ | 700 | $66.64 | $46.6K | +0.6% | Open the original filing on SEC.gov |
| Aug 15, 2025 | GILD | Gilead Sciences, INC. | SSELL◷ | 11,800 | $118.50 | $1.4M | -9.2% | Open the original filing on SEC.gov |
| Aug 15, 2025 | GILD | Gilead Sciences, INC. | MEXER◷ | 11,800 | $66.64 | $786.4K | +10.1% | Open the original filing on SEC.gov |
| Jul 15, 2025 | GILD | Gilead Sciences, INC. | SSELL◷ | 3,000 | $111.03 | $333.1K | -2.5% | Open the original filing on SEC.gov |
| Jun 16, 2025 | GILD | Gilead Sciences, INC. | SSELL◷ | 3,000 | $110.17 | $330.5K | -2.4% | Open the original filing on SEC.gov |
| Jun 10, 2025 | GILD | Gilead Sciences, INC. | MEXER◆ | 3,843 | — | — | — | Open the original filing on SEC.gov |
| Jun 10, 2025 | GILD | Gilead Sciences, INC. | FTAX | 1,827 | $110.09 | $201.1K | -1.5% | Open the original filing on SEC.gov |
| Jun 10, 2025 | GILD | Gilead Sciences, INC. | MEXER | 3,843 | — | — | +3.2% | Open the original filing on SEC.gov |
| May 22, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 1,435 | — | — | — | Open the original filing on SEC.gov |
| May 22, 2025 | NBIX | Neurocrine Biosciences INC | MEXER | 1,435 | — | — | +68.3% | Open the original filing on SEC.gov |
| May 22, 2025 | GILD | Gilead Sciences, INC. | MEXER◷◆ | 12,500 | — | — | — | Open the original filing on SEC.gov |
| May 22, 2025 | GILD | Gilead Sciences, INC. | MEXER◷◆ | 12,500 | — | — | — | Open the original filing on SEC.gov |
| May 22, 2025 | GILD | Gilead Sciences, INC. | SSELL◷ | 3,000 | $107.52 | $322.6K | -2.4% | Open the original filing on SEC.gov |
| May 22, 2025 | GILD | Gilead Sciences, INC. | SSELL◷ | 12,500 | $107.52 | $1.3M | -9.2% | Open the original filing on SEC.gov |
| May 22, 2025 | GILD | Gilead Sciences, INC. | MEXER◷ | 12,500 | $66.64 | $833K | +10.1% | Open the original filing on SEC.gov |
| May 22, 2025 | GILD | Gilead Sciences, INC. | SSELL◷ | 12,500 | $107.52 | $1.3M | -9.2% | Open the original filing on SEC.gov |
| May 22, 2025 | GILD | Gilead Sciences, INC. | MEXER◷ | 12,500 | $66.64 | $833K | +10.1% | Open the original filing on SEC.gov |
| May 21, 2025 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 3,318 | — | — | — | Open the original filing on SEC.gov |